← Back to Clinical Trials
Recruiting NCT05563805

NCT05563805 Exploring Virtual Reality Adventure Training Exergaming

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05563805
Status Recruiting
Phase
Sponsor The University of Texas at Arlington
Condition Physical Activity
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2022-09-07
Primary Completion 2027-08-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Virtual Reality-based physical activity intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2022-09-07 with a primary completion date of 2027-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current project aims to design and implement an 8-week Virtual Reality Adventure Therapy Exergaming (V-RATE) intervention focused on women veterans. A randomized controlled trial using a repeated measure design with a 1-month follow-up assessment will be employed to examine effects on physical and mental health outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Are between the ages of 18 and 45 2. Identify as a U.S. military veteran 4\. Normal vision (no colorblindness) Exclusion Criteria: 1. Unable to walk independently (e.g., use of any mobility assistive device such as brace, wheelchair, cane, crutch, walker, knee scooter) 2. Self-reported joint problem that limits mobility (e.g., arthritis or other condition that would prevent participation) or ongoing orthopedic injury 3. Self-reported pregnancy or suspicion of pregnancy 4. Self-reported motor disorder or impaired sense of motion or balance (such as Parkinsonism) 5. Self-reported color blindness 6. Self-reported neurological or cognitive disorder (e.g., TBI, history of seizure) 7. Self-reported cardiac surgery or any ongoing cardiovascular issues preventing participation or physical activity.

Contact & Investigator

Central Contact

Donna L Schuman, PhD

✉ donna.schuman@uta.edu

📞 18172723181

Frequently Asked Questions

Who can join the NCT05563805 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05563805 currently recruiting?

Yes, NCT05563805 is actively recruiting participants. Contact the research team at donna.schuman@uta.edu for enrollment information.

Where is the NCT05563805 trial being conducted?

This trial is being conducted at Arlington, United States.

Who is sponsoring the NCT05563805 clinical trial?

NCT05563805 is sponsored by The University of Texas at Arlington. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology